Lutetium-177 Market
Lutetium-177 Industry Research Report 2024: Carrier Added Lutetium-177, Non-Carrier-Added Lutetium-177 - Global Forecast 2024-2030
09 sept. 2024 04h56 HE | Research and Markets
Dublin, Sept. 09, 2024 (GLOBE NEWSWIRE) -- The "Lutetium-177 Market by Form (Carrier Added Lutetium-177, Non-Carrier-Added Lutetium-177), Route of Administration (Intravenous, Oral), End User,...
Claritas.png
Claritas NucMed Technologies Secures Approval for its Subsidiary Claritas NucMed Tech Brazil to Forge Ahead the Commercialization of its Cutting-Edge Nuclear Medicine Software Solutions in Brazil
02 sept. 2024 10h00 HE | Claritas HealthTech Ltd
Claritas NucMed Technologies Secures Approval for its Subsidiary Claritas NucMed Tech Brazil to Forge Ahead the Commercialization of its leading SaMDs
North American Nuclear Medicine Market
North America $3.62 Bn Nuclear Medicine Market by Country, Competition, Forecast & Opportunities, 2019-2023 & 2024-2029
26 août 2024 10h52 HE | Research and Markets
Dublin, Aug. 26, 2024 (GLOBE NEWSWIRE) -- The "North America Nuclear Medicine Market, By Country, Competition, Forecast & Opportunities, 2019-2029F" report has been added to ...
22157.jpg
Radiotherapy, Radiopharmaceuticals and Nuclear Medicine Global Markets Research 2021-2029: Increasing Demand in Developing Regions, Applications Beyond Oncology, Theranostics Gaining Traction
21 août 2024 06h57 HE | Research and Markets
Dublin, Aug. 21, 2024 (GLOBE NEWSWIRE) -- The "Radiotherapy, Radiopharmaceuticals and Nuclear Medicine: Global Markets" report has been added to ResearchAndMarkets.com's offering.The global market...
Claritas.png
Claritas HealthTech Announces Spin-Off of Claritas NucMed Technologies Ltd to Lead Global Delivery of its Suite of Software Solutions in Nuclear Medicine
29 juil. 2024 07h30 HE | Claritas HealthTech Ltd
Claritas HealthTech Announces Spin-Off of Claritas NucMed Technologies Ltd to Lead Global Delivery of its Suite of Software Solutions in Nuclear Medicine
Claritas.png
Claritas HealthTech Receives Clearance from Indian Regulator CDSCO for Claritas iPET™ Software in India for Improving Quality and Efficiency of PET-CT & PET-MRI Scans
15 juil. 2024 13h31 HE | Claritas HealthTech Ltd
Claritas HealthTech Receives Clearance from Indian Regulator CDSCO for Claritas iPET™ Software in India for Improving Quality and Efficiency of PET-CT/MRI
Picture1.jpg
Curium Adds the Institut Laue-Langevin Reactor to Global Irradiation Portfolio to Ensure Continuous Supply of Lutetium-177 to Benefit More Than 100,000 Cancer Patients Over the Next 5 Years
05 juin 2024 05h27 HE | Curium
Curium partners with Institut Laue–Langevin to enhance Lutetium-177 supply, benefiting over 100,000 cancer patients in five years.
Curium
Curium Extends Irradiation Partnership With NRG I PALLAS in Netherlands for Continuous Supply of Lutetium-177 to Treat 1,000s of Cancer Patients Each Year
29 mai 2024 03h32 HE | Curium
PARIS, May 29, 2024 (GLOBE NEWSWIRE) -- Curium, a world leader in nuclear medicine, today announced that it has signed a long-term agreement to extend its current partnership with NRG I PALLAS for...
Canadian Nuclear Medicine Market
Canada Nuclear Medicine Market Analysis Report 2024-2030, Featuring Nordion, Lantheus Medical Imaging, Cardinal Health, Jubilant Life Sciences, Isologic Innovative Radiopharmaceuticals & Curium Pharma
24 janv. 2024 05h46 HE | Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Canada Nuclear Medicine Market Size, Share & Trends Analysis Report by Product (Diagnostic, Therapeutic), Application (Oncology, Bone Metastasis,...
SNS-INSIDER-300X300.jpg
Nuclear Medicine Market to Surpass USD 24.20 Billion by 2030 Driven by Rising Prevalence of Chronic Diseases and Favorable Reimbursement Policies | Research by SNS Insider
13 déc. 2023 09h01 HE | SNS Insider pvt ltd
Pune, Dec. 13, 2023 (GLOBE NEWSWIRE) -- “The Nuclear Medicine Market, as per the SNS Insider report, achieved a valuation of USD 9.24 billion in 2022. Anticipated to exhibit substantial growth, it...